Zhuxuan (Kellen) Xu is a Ph.D. student in the Cellular and Molecular Pharmacology program. Kellen is interested in the engineering of CRISPR systems to target disease-associated genes. He also applies bioinformatics tools to analyze gene editing results.
Kellen’s current research project focuses on developing the Pin-point CRISPR system for Duchenne Muscular Dystrophy exon-skipping therapeutics.